The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease

被引:0
|
作者
Hlin Kvartsberg
Tammaryn Lashley
Christina E. Murray
Gunnar Brinkmalm
Nicholas C. Cullen
Kina Höglund
Henrik Zetterberg
Kaj Blennow
Erik Portelius
机构
[1] The Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[2] Sahlgrenska University Hospital/Mölndal,Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders
[3] UCL Institute of Neurology,Department of Neurodegenerative Disease
[4] UCL Institute of Neurology,Clinical Neurochemistry Laboratory
[5] UK Dementia Research Institute at UCL,Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Disease Research, Neurogeriatrics Division
[6] Sahlgrenska University Hospital,undefined
[7] Karolinska Institutet,undefined
来源
Acta Neuropathologica | 2019年 / 137卷
关键词
Neurogranin; Alzheimer’s disease; Brain tissue; Familial Alzheimer’s disease; Mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Synaptic degeneration and neuronal loss are early events in Alzheimer’s disease (AD), occurring long before symptom onset, thus making synaptic biomarkers relevant for enabling early diagnosis. The postsynaptic protein neurogranin (Ng) is a cerebrospinal fluid (CSF) biomarker for AD, also in the prodromal phase. Here we tested the hypothesis that during AD neurodegeneration, processing of full-length Ng into endogenous peptides in the brain is increased. We characterized Ng in post-mortem brain tissue and investigated the levels of endogenous Ng peptides in relation to full-length protein in brain tissue of patients with sporadic (sAD) and familial Alzheimer’s disease (fAD), healthy controls and individuals who were cognitively unaffected but amyloid-positive (CU-AP) in two different brain regions. Brain tissue from parietal cortex [sAD (n = 10) and age-matched controls (n = 10)] and temporal cortex [sAD (n = 9), fAD (n = 10), CU-AP (n = 13) and controls (n = 9)] were included and all the samples were analyzed by three different methods. Using high-resolution mass spectrometry, 39 endogenous Ng peptides were identified while full-length Ng was found to be modified including disulfide bridges or glutathione. In sAD parietal cortex, the ratio of peptide-to-total full-length Ng was significantly increased for eight endogenous Ng peptides compared to controls. In the temporal cortex, several of the peptide-to-total full-length Ng ratios were increased in both sAD and fAD cases compared to controls and CU-AP. This finding was confirmed by western blot, which mainly detects full-length Ng, and enzyme-linked immunosorbent assay, most likely detecting a mix of peptides and full-length Ng. In addition, Ng was significantly associated with the degree of amyloid and tau pathology. These results suggest that processing of Ng into peptides is increased in AD brain tissue, which may reflect the ongoing synaptic degeneration, and which is also mirrored as increased levels of Ng peptides in CSF.
引用
收藏
页码:89 / 102
页数:13
相关论文
共 50 条
  • [41] The clinical phenotype of familial and sporadic late onset Alzheimer's disease
    Holmes, C
    Lovestone, S
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (02) : 146 - 149
  • [42] Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease
    Chatterjee, Madhurima
    Del Campo, Marta
    Morrema, Tjado H. J.
    de Waal, Matthijs
    van der Flier, Wiesje M.
    Hoozemans, Jeroen J. M.
    Teunissen, Charlotte E.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [43] Cerebellar pathology in sporadic and familial Alzheimer's disease: A morphometric investigation
    Fukutani, Y
    Cairns, NJ
    Rossor, MN
    Isaki, K
    Lantos, PL
    BRAIN PATHOLOGY, 1997, 7 (04) : 1203 - 1203
  • [44] Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease
    Condello, Carlo
    Lemmin, Thomas
    Stohr, Jan
    Nick, Mimi
    Wu, Yibing
    Maxwell, Alison M.
    Watts, Joel C.
    Caro, Christoffer D.
    Oehler, Abby
    Keene, C. Dirk
    Bird, Thomas D.
    van Duinen, Sjoerd G.
    Lannfelt, Lars
    Ingelsson, Martin
    Graff, Caroline
    Giles, Kurt
    DeGrado, William F.
    Prusiner, Stanley B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (04) : E782 - E791
  • [45] Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease
    Potter, Huntington
    Granic, Antoneta
    Caneus, Julbert
    CURRENT ALZHEIMER RESEARCH, 2016, 13 (01) : 7 - 17
  • [46] Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study
    Thordardottir, Steinunn
    Almkvist, Ove
    Johansson, Charlotte
    Zetterberg, Henrik
    Blennow, Kaj
    Graff, Caroline
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (03) : 941 - 953
  • [47] AMY plaques in familial AD - Comparison with sporadic Alzheimer's disease
    Lippa, CF
    Schmidt, ML
    Nee, LE
    Bird, T
    Nochlin, D
    Hulette, C
    Mori, H
    Lee, VMY
    Trojanowski, JQ
    NEUROLOGY, 2000, 54 (01) : 100 - 104
  • [48] New transgenic mouse models for familial and sporadic Alzheimer's disease
    Munoz, Diego
    Fernandez, Almudena
    Cantero, Marta
    Gomez, Carmen
    Martin, Javier
    Ortega, Sagrario
    Jesus Bullido, Maria
    Valdivieso, Fernando
    Montoliu, Lluis
    TRANSGENIC RESEARCH, 2011, 20 (05) : 1188 - 1189
  • [49] Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease
    Armstrong, Richard A.
    FOLIA NEUROPATHOLOGICA, 2011, 49 (03) : 153 - 161
  • [50] Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease
    Mori, I
    Kimura, Y
    Naiki, H
    Matsubara, R
    Takeuchi, T
    Yokochi, T
    Nishiyama, Y
    JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (04) : 605 - 611